secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001628280-23-026584
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive raises $4.8M via warrant exercise; issues new warrants at $2.60 strike, expiring 2029
--------------------------------------------------------------------------------

- Exercise of 5M existing warrants at $0.96 yields ~$4.8M gross proceeds to Aquestive.
- Issued new warrants to purchase up to 2.75M shares at $2.60, expiring Feb 2, 2029.
- Company agreed to 30-day lock-up on further securities offerings and no variable-rate transactions.
- Beneficial ownership limitation on new warrants set at 4.99% (option to increase to 9.99%).
- Company to file resale registration statement for new warrant shares within 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828023026584/0001628280-23-026584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828023026584/aqst-20230801.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-026584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer